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Abstract
Background
Hypothyroidism is associated with obesity, and thyroid hormones are involved in the regula-
tion of body composition, including fat mass. Genome-wide association studies (GWAS) in
adults have identified 19 and 6 loci associated with plasma concentrations of thyroid stimu-
lating hormone (TSH) and free thyroxine (fT4), respectively.
Objective
This study aimed to identify and characterize genetic variants associated with circulating
TSH and fT4 in Danish children and adolescents and to examine whether these variants
associate with obesity.
Methods
Genome-wide association analyses of imputed genotype data with fasting plasma concen-
trations of TSH and fT4 from a population-based sample of Danish children, adolescents,
and young adults, and a group of children, adolescents, and young adults with overweight
and obesity were performed (N = 1,764, mean age = 12.0 years [range 2.5−24.7]). Replica-
tion was performed in additional comparable samples (N = 2,097, mean age = 11.8 years
[1.2−22.8]). Meta-analyses, using linear additive fixed-effect models, were performed on the
results of the discovery and replication analyses.
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Results
No novel loci associated with TSH or fT4 were identified. Four loci previously associated
with TSH in adults were confirmed in this study population (PDE10A (rs2983511: β =
0.112SD, p = 4.8  10−16), FOXE1 (rs7847663: β = 0.223SD, p = 1.5  10−20), NR3C2
(rs9968300: β = 0.194SD), p = 2.4  10−11), VEGFA (rs2396083: β = 0.088SD, p = 2.2 
10−10)). Effect sizes of variants known to associate with TSH or fT4 in adults showed a simi-
lar direction of effect in our cohort of children and adolescents, 11 of which were associated
with TSH or fT4 in our study (p<0.0002). None of the TSH or fT4 associated SNPs were
associated with obesity in our cohort, indicating no pleiotropic effects of these variants on
obesity.
Conclusion
In a group of Danish children and adolescents, four loci previously associated with plasma
TSH concentrations in adults, were associated with plasma TSH concentrations in children,
suggesting comparable genetic determinants of thyroid function in adults and children.
Introduction
Thyroid hormone concentrations exhibit a physiological narrow variability within the individ-
ual, but exhibit a considerable inter-individual variability [1]. This could be explained by a
genetic influence, which has been shown to explain 65% of the variation in concentrations of
thyroid stimulating hormone (TSH) and thyroxine (T4) in healthy adults [2]. Nineteen loci
have been found to be associated with circulating TSH and six with free T4 (fT4) concentra-
tions in genome-wide association studies (GWAS) in adults [3–12]. Despite a tight physio-
logical regulation between TSH and fT4, these two hormones do not seem to share genetic
influences [13]. A recent study showed that all common variants could explain ~20% of the
variation in TSH and fT4 concentrations [12]. However, the identified loci specific to TSH
only explained a small part of the variation in TSH concentration, suggesting that a part of
the missing heritability in relation to thyroid hormones might be explained by larger effects
of rare or low-frequency variants [12]. Only a few GWAS on TSH and fT4 have included chil-
dren [9,10]. Only one study in neonates (N = 1,583) has focused exclusively on children, repli-
cating two associations previously identified in adults; one in PDE8B and one upstream of
FOXE1 [14]. The scarcity of studies in children makes it difficult to determine, whether the
loci identified to be important for TSH and fT4 in adults, are also important during childhood
and adolescence. Although associations with certain phenotypes, such as BMI and vitamin D,
identified in adults have been replicated in children [15,16], results from GWAS of BMI in
children and adolescents have also contributed with additional genetic associations [17]. Even
during childhood the effects of genetic variants may act in opposite directions, as exemplified
by a negative influence of some FTO variants in early childhood compared to a positive effect
in later childhood [18], indicating that investigations in children may help explain more of
the time-dependent influence of genetic variation on a given phenotype. The age-dependent
effects of genetic variations on TSH and fT4 were illustrated in a recent study, in which a gene
risk score (GRS) based on studies in adults explained considerably less of the variation in TSH
and fT4 in newborns compared to children at six years of age (TSH 0.8−1.0%, fT4 0.2−0.3%
vs. TSH 5.3−5.5%, fT4 1.9−3.6%) [19]. This difference may be biased by the maternal thyroid
concentrations, which are known to pass the placental barrier. Thus the thyroid function of
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the newborn is not established and stabilized until several days after birth [19,20]. In adults, up
to 7.1% of the variation in serum TSH concentrations and 1.9% of the variation in serum fT4
concentrations have been explained by gene risk scores for the given phenotype [12], thus
there is still unexplained variation in children, not accounted for by the variation described in
studies in adults.
Thyroid hormones are known to fluctuate during growth and development [21], and in
adulthood, concentrations increase with age [22]. Higher concentrations of TSH and lower
concentrations of fT4 have been associated with adiposity in both adults and children [23–28].
In addition, some variants associated with TSH have exhibited an attenuated effect on increas-
ing body mass index (BMI) [4,29]. However, whether measures of thyroid function and adi-
posity have a shared genetic background is not clear. Variations in circulating concentrations
of TSH and fT4, even within the normal range, have been associated with cardiovascular mor-
tality, metabolic syndrome, dyslipidemia, and depression, illustrating the diverse effects of the
thyroid axis [30].
The aim of the present study was to identify genetic variants associated with concentrations
of TSH and fT4 in a cohort of Danish children and adolescents with normal weight and over-
weight/obesity, and to elucidate possible effects on obesity of these associations.
Patients and methods
Study population
A total of 1,876 children, adolescents, and young adults aged 2−25 years with obesity were
recruited from The Children’s Obesity Clinic, Department of Pediatrics, Copenhagen Univer-
sity Hospital Holbæk, at entry into childhood obesity treatment [31]. The only criteria for
inclusion into treatment was a BMI above the 90th percentile for age and sex according to a
Danish reference population [32]. There were no exclusion criteria for entering into
treatment.
As part of The Danish Childhood Obesity Biobank (ClinicalTrials.gov ID-no.:
NCT00928473), a population-based group of 2,555 children and adolescents was recruited
from local schools, where all students between 6 and 22 years of age were invited to
participate.
The only exclusion criterion for the present study was an ethnicity other than Danish/
North-European white (N = 365).
GWAS analyses, with TSH and fT4 as phenotypes, were performed on the discovery batch
comprising 1,900 individuals included from January 2009 to March 2013. The replication
batch consisted of 2,166 individuals recruited from March 2013 to May 2015. The same exclu-
sion criterion applied to both batches.
All participants were examined at baseline with anthropometrics and fasting blood samples
(S1 Table).
All participants received oral and written information and gave informed assent. Informed
written consent was obtained from parents/caretakers of children younger than 18 years of
age, and from participants 18 years of age and older. The study was approved by the Danish
Data Protection Agency, the Regional Ethics Committee of Region Zealand (SJ-104), and was
performed according to the Helsinki Declaration.
Objective clinical measurements
Anthropometrics. Height was measured by stadiometer to the nearest 0.1 cm. Weight
was measured to the nearest 0.1 kg. Measurements were performed without shoes and with the
child wearing light indoor clothes. BMI was calculated as weight in kilograms divided by
Thyrotropin and thyroxine in children and youths; a GWAS
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height in meters squared, and a BMI standard deviation score (SDS) was calculated according
to the LMS method [33] based on Danish reference charts [32].
Blood samples. Blood samples were drawn from the antecubital vein after an overnight
fast. Plasma concentrations of TSH and fT4 were measured on a Cobas 60001 analyzer
(Roche Diagnostics, Manheim, Germany) and on a Dimension Vista (Siemens Healthcare,
Erlangen, Germany) in the discovery and replication batch, respectively. Both devices use
immunologic chemiluminescent analysis methods. Intra-individual coefficients of variation
on the Cobas 60001 were 1.4−2.4% for TSH and 1.7−2.6% for fT4, and on the Dimension
Vista 1.3−1.4% for TSH and 1.8−1.9% for fT4.
Genetic analyses
Genotyping and imputation. DNA was extracted at LGC Genomics (LGC, Middlesex,
United Kingdom). All participants were genotyped with the Illumina Infinium Human Cor-
eExome BeadChip (CoreExomeChip) using Illumina’s HiScan system at the Novo Nordisk
Foundation Centre for Basic Metabolic Research’s laboratory at Symbion, Copenhagen, Den-
mark. The standard pipeline in Illumina Genome Studio software was used for the genotype
calling. A total of 503,035 markers in 1,900 individuals entered the quality control (QC) pipe-
line. Due to a call-rate below 95%, 317 markers were removed. Furthermore, 129 individuals
were excluded due to 1) a call-rate below 95%, 2) extreme positive or negative inbreeding coef-
ficients, 3) ethnic outliers using Principal Component Analysis (PCA) on ancestral markers, 4)
unknown first degree relative relations found by Identical By Descent (IBD) analysis where
only the relative with the highest call-rate for each pedigree-pair was retained, 5) sample dupli-
cates, and 6) sex discrepancy between genotype and phenotype data. In our QC pipeline, we
used a combination of scripts written in Python and R[34] together with PLINK software [35].
This left 1,771 individuals with 502,718 markers available for further analyses.
Haplotypes were phased using SHAPEIT [36] and additional genotypes were imputed by
IMPUTE2, applying the 1000 genomes phase 1 reference panel [37] on all markers that passed
a Hardy-Weinberg Equilibrium (HWE) filter (p<0.005), to a final of ~16.8 million markers.
Markers with a minor allele frequency (MAF) below 1%, an imputation quality below 0.6, or
not in HWE (p<1  10−6) after imputation, were excluded (a total of ~8.3 million markers for
combined QC criteria), leaving ~8.5 million markers for the final analyses. After QC and
imputation 91 individuals were removed due to missing phenotype data, making the final
number for the discovery analysis of both TSH and fT4 1,680 (S1 Fig).
In the replication study, six lead SNPs in 2,166 individuals were genotyped with KASP
SNP Assay (LGC Genomics, Middlesex, UK), while the remaining three lead SNPs failed direct
genotyping. Instead, proxy SNPs were genotyped, using the same platform. Proxies were
selected based on 1) SNP present on the CoreExome chip, to assure well designed assays had
been successfully made earlier, 2) Strongest association to TSH/fT4, and 3) Minimal distance
to the SNP from the discovery analyses which failed to replicate (S2 Table). For rs5997852 no
suitable proxy could be identified using the criteria defined above. Therefore, we identified
other possible proxies for rs5997852 in our discovery cohort. Sixteen SNPs were in high LD
(R2>0.75). rs28360515 showed the highest LD with rs5997852, and was thus selected for repli-
cation (S2 Table). Prior to genotyping the LD was validated in adults in the Inter99 cohort
[38].
In the replication cohort, individuals with self-reported ethnicity other than Danish/North-
European white (N = 37) were removed. In total, 2,129 individuals passed QC with a call-rate
of at least 99% for each of the six SNPs, without using any cut-offs on call-rate. See S1 Table for
basic characteristics of participants included in the analyses.
Thyrotropin and thyroxine in children and youths; a GWAS
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Statistical analyses
The discovery association analyses were performed using an additive linear model imple-
mented in the analytical software SNPTEST (v2) [36], using a frequentist score-test to charac-
terize statistical uncertainty [39]. TSH and fT4 concentrations were transformed to a standard
normal distribution, to avoid phenotypic outliers to skew results, using a rank based inverse
normal transformation. S3 Table shows the skewness and kurtosis for the two phenotypes
before transformation. We identified 11 outliers for TSH and 31 outliers for fT4 (6 were outli-
ers for both TSH and fT4). Outliers were defined as TSH<0.45 mIU/L or >10 mIU/L, or
fT4<11.1 pmol/L or >23.4 pmol/L according to references from pediatric populations and the
cut-off for subclinical hypothyroidism [20,40,41]. All models were adjusted for sex and age.
Additionally, we ran another discovery analysis, adjusted for BMI SDS. We calculated princi-
pal components based on uncorrelated variants. However, since the principal components did
not associate with the phenotypes and ethnic outliers were removed in the genotyping QC, we
did not adjust for principal components in the discovery analysis.
The p-values were adjusted using the method of genomic control (GC) by calculating the
inflation factor (λ) of the p-values as l ¼ medianðw
2
1
ð1  PÞÞ
medianðw2
1
ð0:5ÞÞ
, where w2
1
is the (non-central) chi-squared
distribution with one degree of freedom and p is the observed p-values in the discovery analyses.
The adjusted p-values were then calculated as: padjusted ¼ pw2
1
w2
1
ð1  pÞ
l
 
, where pw2
1
is the probability
distribution for a non-central chi-squared distribution as implemented in the R-function chi-
square from the R-packages stat [42].
In the discovery analysis, a replication threshold of p< 1  10−6 was used in the identifica-
tion of loci with potential associations with TSH or fT4. To test whether the SNPs reaching the
replication threshold were previously known or potentially novel, we performed a conditioned
analysis on each of our lead SNPs, defined as the strongest signal in the locus, dependent on
SNPs on the same chromosome and known to associate with the specific phenotype (S4 Table)
[3–12].
Meta-analysis
The results from the discovery and replication stages were combined in a fixed-effect meta-
analysis, with alleles flipped to match the effect allele from the discovery analysis. We report
the p-values for the two-tailed test on the combined effect. A genome-wide significant thresh-
old of p< 5  10−8 was applied for these analyses. We used the R-package ‘meta’ for these
analyses.
Weighted gene risk score (wGRS)
We used the strongest signal in each locus, known to associate with TSH or fT4 concentrations
in adults, and calculated a weighted gene risk score (wGRS), weighted by the effect per allele as
identified in our discovery analysis. The effect allele in each locus was chosen as the allele that
increased the TSH or fT4 concentrations. The wGRS was then used as the explanatory variable
in an additive linear model on rank normalized TSH and fT4, with age and sex as co-variables.
To estimate how much of the variation was captured by the wGRS, we used ANOVA (analy-
sis-of-variance, type-II) from the car package [43] in R to calculate the sum of squares propor-
tion for the wGRS. The 95% confidence interval (CI95%) for this estimation was calculated
using the standard approach for computing the confidence interval for proportions, by using
the formula in R: CI95% ¼ kN  qnorm 0:975ð Þ 
ffiffiffiffiffiffiffiffiffiffiffiffi
k
N 1 
k
Nð Þ
N
q
, where k is the sum of squares
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proportion for the wGRS, N is the sample size, and qnorm (0.975) is the 97.5th percentile of
the normal distribution.
Associations with obesity and BMI SDS
The associations between obesity, defined as a BMI SDS above 1.28, corresponding to the 90th
percentile for age and sex [32], and the lead SNPs, significantly associated with TSH or fT4 con-
centrations in the meta-analyses, were investigated. Analyses were performed using a logistic
regression model and a case-control design, adjusted for sex and age at baseline. A subgroup of
lean participants from the population-based group, with -1.28BMI SDS1.28 [32] (N =
1,788), was compared to a subgroup with obesity combining the group of children and adoles-
cents from The Children’s Obesity Clinic with the children and adolescents from the popula-
tion-based sample, who had a BMI SDS>1.28 [32] (N = 2,397). As we investigated whether the
selected lead SNPs, significantly associated to TSH or fT4 concentrations, also associated with
obesity, adjusted for sex and age, or with BMI SDS as a continuous variable, using a fixed-effect
meta-analysis, a significance threshold adjusted for multiple testing ad modum Bonferroni of
p< 0.0056 was chosen for these analyses. We used the R-package ‘meta’ for these analyses.
Additional analyses of the VEGFA locus
We investigated associations of two SNPs (rs2396083 and rs6905288) in the VEGFA locus to
the inverse rank normalized waist hip ratio (WHR) in a linear additive model, adjusted for age
and sex, as SNPs in the VEGFA locus have been associated with WHR in European adults
[44]. We also investigated the LD between the two variants using the online tool LDlink [45]
in Europeans from phase 3 of the 1000 Genome Project.
Statistical power
We calculated the statistical power to detect signals above a certain threshold, given a specific
MAF and effect size, by running a linear additive model on a simulated normal distribution
with the same variation as the trait in our study. We then observed how often the model
resulted in a significant test at a given significance level. For each effect size and MAF, we per-
formed the simulation 100 times (S5 Table).
Results
A total of 1,680 individuals were available for the TSH discovery analysis of 8,508,717 genetic
markers. Of these, 183 markers in seven loci reached the replication threshold of p< 1  10−6
in the discovery analyses (Table 1 and Fig 1). When we adjusted for BMI SDS, we observed
comparable results for the seven identified loci and no additional associated loci were detected.
We performed the analyses stratified for sex, which did not reveal additional associated loci
(data not shown).
Of the seven identified loci, four have previously been associated with variations in circulat-
ing TSH concentrations. The remaining three lead SNPs (rs77601015, rs74781923, rs75732991)
were considered markers of potentially novel loci, as they maintained their significance level
after conditioning on known TSH-associated SNPs (Table 1 and S4 Table).
We sought to replicate the seven identified lead SNPs associated with TSH concentrations.
Three of the seven lead SNPs identified in the discovery analyses were significantly associated
(p<0.0056) with TSH concentrations in the replication sample (rs2983511, rs2396083, and
rs9968300). Two lead SNPs (rs7847663 and rs75732991) were unsuccessfully genotyped;
instead proxies were identified and genotyped. In the replication batch the proxy SNP
Thyrotropin and thyroxine in children and youths; a GWAS
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(rs925489) for rs7847663 associated with TSH (p<0.0056) (Table 1). The remaining SNPs
were not significantly associated with TSH concentrations in the replication study (Table 1).
From the discovery and replication sample sets, 3,809 individuals with TSH measurements
were available for meta-analyses. The four SNPs associating significantly with TSH concentra-
tions in the discovery and replication analyses all reached a genome-wide significance
(p<510−8) in the meta-analyses (Table 1). The four identified lead SNPs were all located near
loci previously known to associate with TSH in adults [3].
A total of 1,680 individuals were available for the fT4 analyses. In the discovery analyses, six
markers in two potentially novel loci reached the replication threshold of p< 1  10−6 (Table 1
and Fig 2).
Table 1. Lead SNPs from the discovery-, replication- and meta-analyses.
Info GWAS results Replication Meta-analysis
SNP Locus Effect/Non effect allele EAF Beta SE P EAF Beta SE P Beta SE P
TSH
rs2983511 PDE10A G/C 0.696 0.238 0.038 1.710−9 0.605 0.093 0.015 3.410−10 0.112 0.014 4.810−16
rs7847663* FOXE1 T/C 0.679 0.226 0.037 3.510−9 0.698 0.220 0.031 2.810−12 0.223 0.024 1.510−20
rs77601015 HMHB1 T/C 0.983 1.029 0.178 1.910−8 0.968 -0.198 0.125 1.310−1 0.207 0.102 4.310−2
rs9968300 NR3C2 C/A 0.809 0.253 0.045 4.810−8 0.795 0.152 0.038 6.710−5 0.194 0.029 2.410−11
rs74781923 TECRL C/T 0.989 1.161 0.211 9.310−8 0.970 -0.117 0.184 5.310−1 0.435 0.139 1.710−3
rs75732991* FAM86C1 G/A 0.511 0.188 0.037 9.310−7 0.588 0.011 0.030 7.210−1 0.079 0.023 6.210−4
rs2396083 VEGFA C/G 0.714 0.200 0.040 9.510−7 0.593 0.072 0.015 1.110−6 0.088 0.014 2.210−10
fT4
rs5997852* SMTN G/A 0.483 0.204 0.039 3.410−7 0.481 0.013 0.024 5.910−1 0.063 0.020 1.910−3
rs144590826 FAM205B T/C 0.012 0.863 0.168 4.010−7 0.025 0.001 0.004 7.910−1 0.002 0.014 6.710−1
SNPs are listed according to their association with each of the traits of fasting plasma TSH and fT4 concentrations.
* Indicates a proxy was used for the replication (S6 Table).
https://doi.org/10.1371/journal.pone.0174204.t001
Fig 1. Association of genome-wide variants with plasma TSH concentrations. SNPs are plotted on the x-axis according to their chromosomal
position against the–log10(p-value). The results were considered genome-wide significant with a p<510−8. A threshold for replication was set at
p<110−6.
https://doi.org/10.1371/journal.pone.0174204.g001
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We attempted to replicate the two identified loci. In the replication sample, rs5997852
could not be successfully genotyped, so a proxy was chosen for rs5997852. Neither this proxy
(rs28360515) or rs144590826 associated with fT4 in 2,129 individuals from the replication
batch, nor did they associate at genome-wide significance in the meta-analysis of discovery
and replication studies (Table 1).
The reported effect sizes of known loci on the TSH and fT4 concentrations in adults [3–12]
were compared to the effect sizes in our cohort of children and adolescents (Fig 3 and S6
Table). For all loci, the effects on TSH and fT4 in our cohort were in the same direction as pre-
viously described in the literature in adults. In our study, 17 of 25 loci were nominally signifi-
cantly associated with TSH or fT4 (p<0.05), and 11 remained significant when correcting for
multiple testing ad modum Bonferroni (p<0.0002) (S6 Table). For two SNPs in two loci
(rs10032216 in NR3C2 and rs753760 in PDE10A) the heterogeneity was above 90% and statisti-
cally significant after Bonferonni correction (p< 0.002). The effect size was greater in our
cohort compared to the observe effect in the literature (Fig 3).
The wGRS of SNPs previously known to associate with TSH concentrations also associated
with TSH concentration in the present study (β = 0.053, SE = 0.015, P = 3.210−4), but not with
fT4 concentrations (β = 0.006, SE = 0.015, P = 0.19). Similarly, the wGRS for fT4 associated pos-
itively with fT4 concentrations (β = 0.025, SE = 0.004, P = 7.510−9) in our cohort but not with
TSH concentrations (β = -0.011, SE = 0.004, P = 0.45). The wGRS for TSH explained 0.5% of
the variation in TSH concentrations. The wGRS for fT4 explained 1.8% of the variation in fT4
concentrations. In participants 12 years of age or younger (N = 871), the wGRS explained 0.6%
(CI95%[0.083%-1.1%]) of the variation in TSH concentrations and 3.7%(CI95%[2.5%-5%]) of the
variation in fT4 concentrations. In participants older than 12 years of age (N = 816), the wGRS
explained 0.1%(CI95%[0%-0.3%]) of the variation in TSH concentrations and 0.8%(CI95%[0.2%-
1.4%]) of the variation in fT4 concentrations.
Fig 2. Association of genome-wide variants with plasma fT4 concentrations. SNPs that passed QC are plotted on the x-axis according to their
chromosomal position against their–log10(p-value). The results were considered genome-wide significant with a p<510−8 and a replication threshold
was set at p<110−6.
https://doi.org/10.1371/journal.pone.0174204.g002
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Fig 3. Effects of genetic variants known to associate with plasma TSH or fT4 concentrations. Effects from studies in adults compared to the
effects of the variants in the cohort from the Danish Childhood Obesity Biobank (TDCOB). Effect sizes are shown in standard deviations (SD) of the
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Applying a 5% significance threshold, no associations were found between the four lead SNPs
associated with TSH and fT4 concentrations and obesity, defined as a BMI SDS>1.28 or BMI
SDS as a continuous variable, when combining 3,894 individuals (1,497/2,397 obese/lean) from
both the discovery and replication sample sets in a meta analysis (S7 Table and S2A–S2D Fig).
We investigated two variants in the VEGFA locus; our lead SNP: rs2396083 and the variant
rs6905288, which have been found to associate with WHR [44]. We saw no LD between the
two variants in the European population (D’ = 0.0024, R2 = 0.0 using LDlink [45]), and found
no association with WHR for either variant in our discovery set (Prs2396083 = 0.42, Prs6905288 =
0.29). Further adjusting for BMI SDS in this analysis did not alter this result (data not shown).
Discussion
In a GWAS of 1,680 children and adolescents and replication in an additional set of 2,129 chil-
dren and adolescents, four SNPs reached genome-wide significance for their associations with
TSH concentrations (PDE10A (rs2983511), FOXE1 (rs7847663), NR3C2 (rs9968300), VEGFA
(rs2396083)). These four loci have all previously been associated with serum TSH concentra-
tions in adults [3].
From the literature we identified 32 SNPs in 19 loci previously found to associate with TSH
or fT4 concentrations in adults [3–12], 25 of which were present in our study. When compar-
ing effect sizes of 25 of the 32 SNPs in our cohort of children and adolescents with effects
described in the literature, the same directional effects were observed with predominantly
overlapping CI95%. The NR3C2 locus and one of the SNPs in the PDE10A locus (rs753760)
seemed to have a larger effect in our cohort. However, as we compared beta-values between
studies, each on their own rank normalized scale, we cannot prove any actual difference in
effect. The heterogeneity between our cohort and the cohort from the literature was>90% for
both loci. This difference may be genuinely due to different effects in adults and children, but
could also be due to gene-gene or gene-environment interactions. In comparison, among the
previous studies of children, one cohort included children as young as 8 years of age, however,
the combined meta-analysis consisted mostly of adults [3]. The NR3C2 locus has been impli-
cated in the insulin-like growth factor’s effects on thyroid function, and the difference could
be explained by fluctuating concentrations of insulin-like growth factor during growth and
development in childhood, before settling at a lower level in adulthood [3,46].
From the SNPs previously found to associate with either TSH or fT4 concentrations, two
wGRSs were computed. These wGRSs were positively associated with TSH and fT4 concentra-
tions in our cohort. The wGRSs were specific to either TSH or fT4 concentrations, i.e. the GRS
for fT4 did not associate with TSH concentrations and vice versa. This is in line with twin stud-
ies of the heritability of thyroid variables showing that levels of both TSH and fT4 are heritable,
but do not share genetic influence [13]. In our cohort, the wGRS explained 0.5% of the varia-
tion in TSH concentrations and 1.8% of the variation in fT4 concentrations. A larger degree of
the variation in both TSH and fT4 concentrations tended to be explained by the wGRS in
younger age (<12 years of age). Compared to studies in adults, the wGRS explained less of the
variation in plasma TSH concentrations and, in children older than 12 years, less of the varia-
tion in fT4 concentrations [12]. The wGRS in the youngest part of our cohort also explained
considerably less of the variation in TSH concentrations compared to what has been found in
a group of 6-year-old children [19].
rank-normalized TSH or fT4 distribution with 95% confidence intervals. EA is the Effect Allele (from the literature). I2 is the measure for heterogeneity
between the TDCOB cohort and literature. p(Hetro) is the p-value for the heterogeneity.
https://doi.org/10.1371/journal.pone.0174204.g003
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Variations in TSH and fT4 concentrations, even within the normal range, have been associ-
ated with variations in BMI and body composition in both children and adults [13,28,27]. In a
study by Malinowski et al. in 4,501 European American individuals, three SNPs in two loci asso-
ciated with TSH (NFIA (rs10489909), NRG1 (rs2466067, rs4298457)) were also associated with
BMI in adults [4]. We did not find any association between our lead SNPs and childhood obe-
sity or BMI SDS as a continuous variable. This is in line with another study in 867 children with
obesity [29], investigating the effects of variations in PDE8B on TSH concentrations, which is
strongly expressed in the thyroid gland [47], finding these effects to be independent of BMI, but
with an additive effect of BMI on TSH concentrations [29]. The three SNPs reported to be asso-
ciated with BMI in adults [4] did not associate with plasma TSH concentrations in our cohort.
One of the loci, VEGFA, in which one of our lead SNPs is located, has previously been asso-
ciated with WHR, which is a marker of abdominal adiposity, however, in line with our study,
they did not find any association to BMI [44]. We did not find any association between two
SNPs in this locus and WHR in our study. We did not find any published GWAS implicating
the PDE10A, FOXE1, or NR3C2 loci in obesity related diseases. Thus our results suggest, that
the associations between TSH and the PDE10A, FOXE1, and NR3C loci could be independent
of BMI SDS.
The strengths of the present study were a group of ethnically homogeneous Danish/North-
European White children, with a prospectively collected cohort, which enabled replication in
another part of our own cohort. Finally, the construction of the cohort with lean controls and
cases with obesity enabled us to estimate the influence of the TSH associated SNPs on child-
hood obesity. A thorough questionnaire provided comprehensive information on medications
and other diseases enabling exclusions of individuals with secondary changes in thyroid func-
tion. We performed sensitivity analyses excluding individuals with known thyroid disease,
individuals taking medications known or suspected to influence thyroid function [48], and
individuals with known or suspected syndromes or monogenic obesity (N = 43), which did
not change the results. We therefore proceeded with reporting on the entire cohort.
We found three possible novel variants associating with TSH in the discovery phase, but
lacked statistical power (S5 Table) to determine if these findings were true. We sought to over-
come this obstacle by replicating in another batch of the cohort, but were unsuccessful in find-
ing any novel associations. Consequently, we were only able to replicate previously found loci
from studies in adults. We did not have enough statistical power to find loci with smaller effect
sizes identified in larger studies in adults, but we do generally observe similar effects in chil-
dren for these loci. We were unable to identify any associations acting differently in our cohort
of children and adolescents than what has been reported in adults.
In conclusion, PDE10A (rs2983511), NR3C2 (rs9968300), FOXE1 (rs7847663), and VEGFA
(rs2396083), which have all previously been associated with TSH concentrations in adults,
associated with TSH concentrations in a group of children and adolescents. The four identified
loci showed similar effects on TSH concentrations as previously reported in adults, suggesting
comparable genetic determinants of thyroid function in adults and children.
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analysis.
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S2 Fig. Forest plots for meta-analyses of associations between rs2983511 and BMI SDS.
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p<110−6 in the discovery analysis (N = 1,680), and the power to detect signals with a p-value
under the GWAS significance threshold of p<510−8 in the meta-analysis (N = 4,224), are
given. The power to detect the odds ratio (OR) of overweight is calculated with a prevalence of
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